carcinogeniesis in mice, in the absence of demonstrable carcinogenic potency of its owIn (Poel, 1965) . The biologic effects of the hormone were described to be typically co-carcinogenic (Poel. 1967) . The present report confirms the observatiol that progesterone, in viral and in chemically induced mammary carcinogenesis, acts as a co-carcinogen; i.e., an agent lacking in carcinogenic potencv which enhances the neoplastic response of a tissue to a carcinogen. The findings suggest also a bioassay technique which exploits differences in spontaneous tumor susceptibilities of inbred strains of mice, to differentiate between co-carcinogenic and carcinogenic potency. at least for progestins.
MATERIALS, METHODS, AND RESULTS
Tl'able I outlines one experiment to ascertain the effects of exogenous progesterone in intact C3HeB virgin female mice, a sub-line presumably free of inammary tumor virus (MTV) . Five groups of mice, initially 8 weeks of age.
were used. In 30 mice of Group 1, the effect of progesterone in enhancing chemical carcinogeniesis was estimated by administering 2-5 mg progesterone in 0 05 ml. peallut oil subcutaneously 5 times a week for 19 weeks, and 0 25 mg. methylcholanthrene (MCA) in 0-1 ml. Tween 60, by gastric lavage (gavage), twice a week. until a mammary tumor nodule was detected. Gavage feeding of MCA began 2 By contrast, cutaneous applications of MCA on C57L mice induce skin malignancies rather than mammary tumors, and those are not influenced by concurrent administration of progesterone. Because of differences in host reactivity and the lhistogenesis of the tumors, bioassays of progesterone for co-carcinogenic enhanleement of skin carcinogenesis were negative with the C57L as the test strain, just as tests for enhanced pituitary tumor development associated with the feeding of svnthetic progestin mixtures were negative with C3H and C57/Black 6 mice (Poel. 1966 and 1967) . Paired inbred strains, carefully selected because of dlifferenices in their tumor propensities. thus appear essential for long-term bioassays, in lieu of just 1 strain of inbred test animal. Indirectly, these observations indicate also the need for parallel studies with random-bred mice, to enable t-he scientist to relate the highly refined reactions of the inbred animal to an experimental model more akin to a population-at-large.
The reported findings confirm the preliminary observation (Poel, 1965) or agents (urethane, viruses) that themselves were later found to be carcinogenic (Clayson. 1966; Kawamoto et al., 1958; Poel, 1956 : Roe, 1956 Salaman, 1958: Salaman and Roe, 1964; Tannenbaum and Silverstone. 19,58; Tannenbaum, 1964: Van Duuren, 1968 (Berenblum, 1968: (layson. 1966: Salaman and Roe. 1964: Kawamoto et al.. 1958 (Poel, 1963) . The existence of a class of co-carcinogens for the skin thus remains a theoretical or speculative possibility requiring experimental validation. Existence of the phenomenon of co-carcinogenesis, however, apparently may be exemplified by enhancement of mammary carcinogenesis with progesterone, an agent demonstrably negative in all tests to date for carcinogenic potency. In that regard, the findings of Bern, Moore, and others may be interpreted to indicate the need to re-investigate the role of other hormones, to ascertain whether they too may not be acting as co-carcinogens, i.e., non-carcinogenic enhancers of target tissues responding to environmental carcinogens.
SUMMARY
A carcinogenicity bioassay, based upon the differential responsiveness of two inbred strains of mice with contrasting spontaneous tumor proclivities, showed exogenous progesterone to be a potent co-carcinogen for viral or chemical induction of mammary cancer in mice, although non-carcinogenic by itself. The findings emphasize the need to limit the term " co-carcinogen " to non-carcinogenic cofactors, other than solvents, which enhance the neoplastic responsiveness of a host's tissue to a carcinogen.
